Within the context of tumor cells, myeloid-derived suppressor cells are stimulated to upregulate programmed death ligand 1 (PD-L1) on their cell surface, engaging in immune checkpoint modulation that impacts T cell responses [57,58,59]. The gene discussed is CD274; the disease is neoplasm.